Skip to main content
. 2024 Spring;24(1):6–13. doi: 10.31486/toj.23.0073

Table 5.

Preoperative and Postoperative 12-Item Short Form Survey Physical Component Score (PCS) and Mental Component Score (MCS)

Treatment Group
AMUC Group PRP Group Control Group
Time Point PCS MCS PCS MCS PCS MCS
Baseline 34.58 ± 8.98 49.10 ± 12.40 51.82 ± 9.92 37.28 ± 8.70 51.36 ± 10.43 35.33 ± 10.20
3 months 40.75 ± 10.09 51.57 ± 10.60 53.98 ± 10.74 40.32 ± 10.99 51.41 ± 11.95 37.67 ± 12.80
0.0668 0.5216 0.4792 0.3133 0.9833 0.3534
6 months 47.44 ± 9.45 52.73 ± 15.13 52.81 ± 8.78 37.82 ± 10.50 48.30 ± 11.65 42.90 ± 14.01
0.0103 0.5796 0.7459 0.8733 0.2623 0.0170
12 months 47.70 ± Low n 42.60 ± Low n 51.89 ± 17.05 29.03 ± 2.06 42.33 ± 14.90 48.48 ± 11.57
0.9965 0.0179 0.0960 0.0059

Notes: Data are presented as mean ± SD. The term Low n indicates inadequate sample size. For the 12-Item Short Form Survey physical component score (PCS) and mental component score (MCS), higher scores indicate better outcomes. P values reflect the statistical significance of the change from baseline.

AMUC, amniotic umbilical cord tissue; PRP, platelet-rich plasma.